Patents by Inventor Naoya Murata

Naoya Murata has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10865246
    Abstract: The present invention provides an anti-PD-L1 antibody capable of staining tumor cells such as melanoma cells. An anti-PD-L1 antibody comprising (a) a light chain comprising CDR1 having the amino acid sequence of KSISKY (SEQ ID NO: 1), CDR2 having the amino acid sequence of SGS and CDR3 having the amino acid sequence of QQHNEYPLT (SEQ ID NO: 2) and (b) a heavy chain comprising CDR1 having the amino acid sequence of GYTFTDYI (SEQ ID NO: 3), CDR2 having the amino acid sequence of INPDSGGN (SEQ ID NO: 4) and CDR3 having the amino acid sequence of ARGITMMVVISHWKFDF (SEQ ID NO: 5). A composition for detecting PD-L1, comprising the above antibody as an active ingredient. A method for preparing the above antibody is also provided.
    Type: Grant
    Filed: March 23, 2018
    Date of Patent: December 15, 2020
    Assignees: Fuso Pharmaceutical Industries, Ltd., National University Corporation Hokkaido University
    Inventors: Satoru Konnai, Kazuhiko Ohashi, Shiro Murata, Tomohiro Okagawa, Asami Nishimori, Naoya Maekawa, Satoshi Takagi, Yumiko Kagawa, Yasuhiko Suzuki, Chie Nakajima
  • Publication number: 20200374893
    Abstract: A first communication apparatus includes a reception unit configured to receive information about uplink quality of user equipment from a second communication apparatus, when the user equipment communicates with both the first communication apparatus and the second communication apparatus; and a control unit configured to control uplink data transmission by the user equipment based on the information about uplink quality.
    Type: Application
    Filed: May 10, 2018
    Publication date: November 26, 2020
    Applicant: NTT DOCOMO, INC.
    Inventors: Teruaki Toeda, Tooru Uchino, Akihito Hanaki, Naoya Murata
  • Patent number: 10843998
    Abstract: A method of producing a bis-acyloxylated exomethylene compound represented by general formula (III), including reacting a monoacyloxylated exomethylene compound represented by general formula (I), a carboxylic acid represented by general formula (II), and oxygen in a liquid phase in the presence of a catalyst and optionally a solvent:
    Type: Grant
    Filed: July 23, 2018
    Date of Patent: November 24, 2020
    Assignee: KURARAY CO., LTD.
    Inventors: Yusuke Murata, Naoya Minamoto, Mitsumasa Kaneko, Ryosuke Shimizu
  • Publication number: 20200283367
    Abstract: A method of producing a bis-acyloxylated exomethylene compound represented by general formula (III), including reacting a monoacyloxylated exomethylene compound represented by general formula (I), a carboxylic acid represented by general formula (II), and oxygen in a liquid phase in the presence of a catalyst and optionally a solvent:
    Type: Application
    Filed: July 23, 2018
    Publication date: September 10, 2020
    Applicant: KURARAY CO., LTD.
    Inventors: Yusuke MURATA, Naoya MINAMOTO, Mitsumasa KANEKO, Ryosuke SHIMIZU
  • Publication number: 20200131270
    Abstract: The present invention provides a novel therapeutic strategy using an inhibitor targeting PD-1/PD-L1. A pharmaceutical composition which comprises a COX-2 inhibitor and is administered before, after or simultaneously with the administration of an inhibitor targeting PD-1/PD-L1. A potentiator for the immunostimulatory effect of an inhibitor targeting PD-1/PD-L1, which comprises a COX-2 inhibitor.
    Type: Application
    Filed: July 19, 2018
    Publication date: April 30, 2020
    Applicants: NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY, FUSO PHARMACEUTICAL INDUSTRIES, LTD.
    Inventors: Satoru KONNAI, Kazuhiko OHASHI, Shiro MURATA, Tomohiro OKAGAWA, Naoya MAEKAWA, Asami NISHIMORI, Shinya GOTO, Yasuhiko SUZUKI, Chie NAKAJIMA, Yamato SAJIKI
  • Publication number: 20200031932
    Abstract: The present invention provides an anti-PD-L1 antibody capable of staining tumor cells such as melanoma cells. An anti-PD-L1 antibody comprising (a) a light chain comprising CDR1 having the amino acid sequence of KSISKY (SEQ ID NO: 1), CDR2 having the amino acid sequence of SGS and CDR3 having the amino acid sequence of QQHNEYPLT (SEQ ID NO: 2) and (b) a heavy chain comprising CDR1 having the amino acid sequence of GYTFTDYI (SEQ ID NO: 3), CDR2 having the amino acid sequence of INPDSGGN (SEQ ID NO: 4) and CDR3 having the amino acid sequence of ARGITMMVVISHWKFDF (SEQ ID NO: 5). A composition for detecting PD-L1, comprising the above antibody as an active ingredient. A method for preparing the above antibody is also provided.
    Type: Application
    Filed: March 23, 2018
    Publication date: January 30, 2020
    Inventors: Satoru Konnai, Kazuhiko Ohashi, Shiro Murata, Tomohiro Okagawa, Asami Nishimori, Naoya Maekawa, Satoshi Takagi, Yumiko Kagawa, Yasuhiko Suzuki, Chie Nakajima
  • Patent number: 10477732
    Abstract: A light irradiation device includes a light emitting unit, a cooling unit, a supply unit, and a driving unit. The light emitting unit emits light while generating heat. The cooling unit includes a channel through which a coolant flows, a first surface on which the light emitting unit is mounted, and a second surface that faces a direction opposite to the first surface. The supply unit is disposed facing the second surface in one direction that the second surface faces and supplies the coolant to the cooling unit. The driving unit is disposed facing the second surface in the one direction and includes a driving board that drives the light emitting unit.
    Type: Grant
    Filed: April 3, 2018
    Date of Patent: November 12, 2019
    Assignee: FUJI XEROX CO., LTD.
    Inventors: Michiaki Murata, Akira Sakamoto, Atsuyuki Kitamura, Hiroyuki Tsukuni, Akira Mihara, Naoya Kamigaito, Satoshi Tejima, Junichiro Hayakawa
  • Publication number: 20190185568
    Abstract: The present invention provides an anti-PD-1 antibody capable of repeated administration even to animals other than rat. An anti-PD-1 antibody comprising (a) a light chain comprising a light chain variable region containing CDR1 having the amino acid sequence of QSLEYSDGYTY (SEQ ID NO: 16), CDR2 having the amino acid sequence of GVS and CDR3 having the amino acid sequence of FQATHDPDT (SEQ ID NO: 17) and the light chain constant region of an antibody of an animal other than rat; and (b) a heavy chain comprising a heavy chain variable region containing CDR1 having the amino acid sequence of GFSLTSYY (SEQ ID NO: 18), CDR2 having the amino acid sequence of IRSGGST (SEQ ID NO: 19) and CDR3 having the amino acid sequence of ARTSSGYEGGFDY (SEQ ID NO: 20) and the heavy chain constant region of an antibody of an animal other than rat. A pharmaceutical composition comprising the above-described anti-PD-1 antibody as an active ingredient. A method for preparing the anti-PD-1 antibody is also provided.
    Type: Application
    Filed: August 10, 2017
    Publication date: June 20, 2019
    Inventors: Satoru Konnai, Kazuhiko Ohashi, Shiro Murata, Tomohiro Okagawa, Asami Nishimori, Naoya Maekawa, Yasuhiko Suzuki, Chie Nakajima
  • Publication number: 20190169294
    Abstract: The present invention provides an anti-LAG-3 antibody capable of repeated administration even to animals other than rat. An anti-LAG-3 antibody comprising (a) a light chain comprising a light chain variable region containing CDR1 having the amino acid sequence of QSLLDSDGNTY (SEQ ID NO: 16), CDR2 having the amino acid sequence of SVS and CDR3 having the amino acid sequence of MQATHVPFT (SEQ ID NO: 17) and the light chain constant region of an antibody of an animal other than rat; and (h) a heavy chain comprising a heavy chain variable region containing CDR1 having the amino acid sequence of GFDFDTYP (SEQ ID NO: 18), CDR2 having the amino acid sequence of ITIKTHNYAT (SEQ ID NO: 19) and CDR3 having the amino acid sequence of NREDFDY (SEQ ID NO: 20) and the heavy chain constant region of an antibody of an animal other than rat. A pharmaceutical composition comprising the above anti-LAG-3 antibody as an active ingredient. A method for preparing the above anti-LAG-3 antibody is also provided.
    Type: Application
    Filed: August 10, 2017
    Publication date: June 6, 2019
    Inventors: Satoru Konnai, Kazuhiko Ohashi, Shiro Murata, Tomohiro Okagawa, Asami Nishimori, Naoya Maekawa, Yasuhiko Suzuki, Chie Nakajima
  • Publication number: 20150253842
    Abstract: A semiconductor device according to an embodiment includes a transmission circuit unit including a physical unit configured to receive, from a connector for connecting to an external appliance configured to transmit a power supply signal and an identification signal, the power supply signal and the identification signal, the transmission circuit unit being configured to be able to perform data communication with the external appliance, and a power control unit configured to perform power control based on a power saving mode and a normal mode, the power control unit being configured to stop power supply to the transmission circuit unit in the power saving mode, and, to detect a connection event of the external appliance to the connector based on the power supply signal and the identification signal and to start power supply to the transmission circuit unit.
    Type: Application
    Filed: September 4, 2014
    Publication date: September 10, 2015
    Inventor: Naoya Murata
  • Publication number: 20100005327
    Abstract: A USB host controller includes: a suspend signal generating unit configured to generate a suspend signal for stopping the operation of a PLL circuit and output the signal to a physical layer including the PLL circuit if there is no communication between a USB device and a CPU in a first mode state of using a clock signal generated by the PLL circuit to transfer data between the USB device and the CPU; and a controller configured to generate the suspend signal for stopping the operation of the PLL circuit and output the signal to the physical layer in a connection waiting state in which the USB device is not connected and in a second mode state of transferring the data between the USB device and the CPU without using the clock signal generated by the PLL circuit.
    Type: Application
    Filed: April 30, 2009
    Publication date: January 7, 2010
    Applicant: KABUSHIKI KAISHA TOSHIBA
    Inventor: Naoya Murata
  • Patent number: 7306423
    Abstract: A linear moving mechanism includes a guide member providing a horizontal straight transport path, a moving member movable along the transport path and a drive mechanism which drives the moving member. The drive mechanism includes a first link arm pivotable around a first vertical shaft, and a second link arm having a first end and a second end. The first vertical shaft is on the transport path or on a line parallel to the transport path. The first end is connected to the first link arm for pivotal movement of the second link arm in a horizontal plane, whereas the second end is connected to the moving member for pivotal movement of the second link arm in a horizontal plane.
    Type: Grant
    Filed: April 14, 2004
    Date of Patent: December 11, 2007
    Assignee: Daihen Corporation
    Inventors: Hironori Ogawa, Takafumi Uratani, Masayuki Sugane, Yoshiyuki Matsuzaki, Naoya Murata, Sakiko Uno
  • Publication number: 20050036877
    Abstract: A linear moving mechanism includes a guide member providing a horizontal straight transport path, a moving member movable along the transport path and a drive mechanism which drives the moving member. The drive mechanism includes a first link arm pivotable around a first vertical shaft, and a second link arm having a first end and a second end. The first vertical shaft is on the transport path or on a line parallel to the transport path. The first end is connected to the first link arm for pivotal movement of the second link arm in a horizontal plane, whereas the second end is connected to the moving member for pivotal movement of the second link arm in a horizontal plane.
    Type: Application
    Filed: April 14, 2004
    Publication date: February 17, 2005
    Applicant: DAIHEN CORPORATION
    Inventors: Hironori Ogawa, Takafumi Uratani, Masayuki Sugane, Yoshiyuki Matsuzaki, Naoya Murata, Sakiko Uno